fda tirzepatide decision to reconsider removal of Eli Lilly weight loss drug from shortage list US judge sides with FDA's

Patients should maintain adequate hydration, particularly during the first weeks of treatment, and report persistent abdominal pain, yellowing skin, or rapid heart rate immediately

Many patients starting Zepbound (tirzepatide) for weight management wonder about potential side effects, including whether the medication causes increased sweating

Every dose change is reviewed by a licensed provider

Based on current clinical trial data, tirzepatide (Zepbound/Mounjaro) at the 15 mg dose produces the highest average weight loss approximately 2022% of body weight, or around 48 lbs on average in the SURMOUNT-1 trial

At Pure Med Spa Chicago, trained professionals ensure a comfortable and effective treatment experience

However, 'better' on paper does not always mean 'better' for every individualsome patients tolerate semaglutide's single-pathway mechanism more comfortably